Was surveillance (follow-up) for local recurrence in the affected eye done? 102 responses I. The Patient Journey Surveillance of Primary Tumor
2% Unknown
The 10% of patients who responded “No” reported:
10% No
Country of residence:
10% Canada 10% Ireland 10% Norway
(1 response)
88% Yes
(1 response)
The 88% of patients who responded “Yes” reported:
(1 response)
Country of residence:
70% United States (7 responses)
Australia (1 response)
1%
US region:
7% Canada
29% West
(6 responses) Mexico (1 response) New Zealand (1 response) Slovenia (1 response)
(2 responses)
1%
14% Midwest 14% Southwest (1 response) (1 response) 43% Southeast
1%
1%
(3 responses)
89% United States (80 responses)
US region:
25% West
15% Midwest
24% Northeast
(20 responses)
(12 responses)
(19 responses)
9% Southwest
27% Southeast
(7 responses)
(22 responses)
2023 VISION Registry Data Report
24
Made with FlippingBook Ebook Creator